European Innovation Council grant

EMPE Diagnostics has received €2.49 million grant from European Innovation Council(EIC) Accelerator Program. It is a great honor and iconic recognition for EMPE Diagnostics!

Month: April 2021
Read More..

Inauguration of EMPE Diagnostics India

On Wednesday March 31, 2021 was held the official inauguration of EMPE Diagnostics Private Limited Global Production facility at Genome Valley in Hyderabad (India).

Month: March 2021
Read More..

The team is growing.

We at EMPE are continuing to grow and are now happy to welcome three more people to the team! Dr. Sanjeev Kumar Gupta is an accomplished QMS, Regulatory and Technical professional having 25 years of experience in the field of Medical Device and In Vitro Diagnostic Devices. He holds a doctorate in Biotechnology from IIT-Roorkee & […]

Month: June 2020
Read More..

New colleagues

EMPE Diagnostics is growing and we would like to give a warm welcome to some new employees. David Herthnek (CSO) holds a MSc in Biotechnology from Linköping University and completed his PhD in Molecular Biology on diagnostic method development at the Swedish National Veterinary Institute. David started his career as a researcher and worked for […]

Posted April 26, 2020
Read More..

India-Sweden Year of Health.

Their Majesties, King Carl XVI Gustaf and Queen Silvia of Sweden visited India with an official delegation on the occasion of ‘India-Sweden Year of Health’, celebrating 10 years of Health Cooperation. Swecare’s video ( captured the most important moments, in the last 10 years. It is absolutely a great honour for EMPE diagnostics to make […]

Posted December 20, 2019
Read More..

2019 World Conference on Access to Medical Products.

Our CEO, Dr. Pavan Asalapuram has presented a poster about the clinical performance validations of our first product, mfloDX® miniMDR-TB test kit at the 2019 World Conference on Access to Medical Products Achieving the SDGs 2030 organised by India and WHO. It was great when the Director General of ICMR, Indian Ministry of Health, visited […]

Posted November 15, 2019
Read More..

Presentation of our first product, mfloDX® miniMDR-TB test.

Professor Sven Hoffner, our advisor presented a poster about the clinical performance validations of our first product, mfloDX® miniMDR-TB test kit at the 50th Union World Conference on Lung Health will take place in Hyderabad, India.

Posted October 26, 2019
Read More..

EMPE Diagnostics hosted students from Uppsala University

EMPE diagnostics has offered an industrial project to a group of Applied Biotechnology MSc students from Uppsala University as a part of their Innovation Management and Entrepreneurship program. Supervised by the core team of EMPE, the students stepped into shoes of young entrepreneurs and analyzed the Chinese market as a potential entry point for EMPE. […]

Posted July 4, 2019
Read More..

EMPE Diagnostics presented at Vitalis 2019

We presented our innovation and products at Vitalis 2019. Great Swedish venue and wide Nordic audience! Would you like to know more about the current activities at EMPE Diagnostics? Read about us at our associate, Sciety’s page::

Posted May 23, 2019
Read More..

100 best Nordic Impact Startups

EMPE Diagnostics has been nominated as one of the 100 best Nordic Impact Startups, building a business to solve societal and environmental problems! Thank you for recognizing us, Norrsken Foundation! For more det

Posted April 2, 2019
Read More..

Announcing our first product: mfloDx® MDR-TB

Another great moment for EMPE Diagnostics when the CEO, Pavan Asalapuram announced the company’s first rapid detection test kit for MDR-TB, in front of Ms. Lena Hallengren (Minister for Health and Social Affairs Sweden), Mrs. Preeti Sudan (Secretary, Ministry of Health & Family Welfare, Government of India), and Dr. Balram Bargava (Director-General at the Indian […]

Posted March 4, 2019
Read More..


The recently awarded INNOVA4TB project is an international and intersectoral consortium that combines research institutions, clinicians, as well as small and medium-size enterprises (SMEs) for the management of M/XDR-TB from high and medium/low Tuberculosis (TB) incidence countries. The kickoff meeting was held on 24-25 Jan. 2019 at IGTP, Badalona. More details can be found at […]

Posted February 25, 2019
Read More..

EMPE Diagnostics receives prestigious EU funding

Marie Skłodowska-Curie Actions Horizon 2020 RISE program has granted 1.3 million euros from the development of new methods of diagnosis and treatment of tuberculosis in a network project called Innovation in Tuberculosis – INNOVA4TB. We are happy to be a part of INNOVA4TB project, a collaborative initiative between 12 institutions from 6 countries (Spain, Sweden, […]

Posted January 8, 2019
Read More..

EMPE Diagnostics listed on the FIND’s Diagnostics Pipeline Tracker

Foundation for Innovative New Diagnostics, FIND. As stated on FINDs website “Diagnosis is the first step on the path to treatment and the foundation of disease control and prevention”. FIND focuses on providing diagnostic solutions where they are needed, provides guidelines, policies as well as providing understanding of the diagnostic value in the community. EMPE […]

Posted December 13, 2018
Read More..

EMPE presentation at WHO conference!

It was a great honor to represent Sweden and present our unique diagnostic solutions for the early-stage detection of bacterial infections and rapid genotyping of multidrug-resistant tuberculosis in the 2nd WHO conference held in New Delhi! A hearty thanks to all our Team Sweden, including Swedish Embassy, SweCare Foundation, Swedish Medtech, EMPE Diagnostics AB, ApiRays […]

Posted November 19, 2018
Read More..

We are entering India! Happy present our experience at “Entering markets outside EU – CB Health Access” seminar in Stockholm.

We are entering India! Happy present our experience at “Entering markets outside EU – CB Health Access” seminar in Stockholm.

Posted September 10, 2018
Read More..

Catharina Lagerstam is the new Chairman!

EMPE is happy to announce that Catharina Lagerstam, who is well-known in the Swedish Finanical and Banking industry is taking charge as the new Chairman of the board. Welcome Catharina!

Posted August 15, 2018
Read More..

Successfully generated Series A investment!

We are happy to announce that EMPE Diagnostics has secured a 10 MSEK investment.

Posted June 1, 2018
Read More..

EMPE Diagnostics has been recognised by SwedenBIO and has become a part of the Swedish Precision Medicine Industry Landscape.

We are overwhelmed for the recognition by SwedenBIO that launched the Precision Medicine – The Swedish Industry Guide 2018! SwedenBIO has launched a major new report representing the first effort to map the Swedish Precision Medicine Industry Landscape and showcase precision medicine companies in Sweden to the global life science community.

Posted April 2, 2018
Read More..

Seeking Seires A investments!

We are going with Sciety, an authorised Swedish financial private organisation. Invest in us for the future!

Posted March 3, 2018
Read More..

Started clinical validation in Spain!

We are happy to announce the first phase of our clinical validation initiation at The Institute for Health Science Research Germans Trias i Pujol (IGTP).

Posted January 12, 20186
Read More..

Going to India: Participation in InnoHealth 2017

InnoHEALTH 2017 is the second in the series of InnoHEALTH annual conferences in India, building on the success of InnoHEALTH 2016 which saw 200 participants from the World Health Innovation Network, Canada, Talent grid Ventures, Singapore, ScanBalt Forum, and Europe. The focus of this conference is to bring together the ‘innovations in healthcare’. EMPE Diagnostics […]

Posted September 2, 2017
Read More..

Joining the Central Baltic Health Access and Swecare

Swecare is a Swedish Govt. initiative that helps interactions between academia and public and private sectors, to join forces toward enhanced export and internationalization of Swedish health care and life sciences. EMPE Diagnostics is the only Molecular Diagnostic company among 9 companies that were selected to participate in the Central Baltic Health Access initiated by […]

Posted August 1, 2017
Read More..

EMPE is selected for round-table discussion at ESM 2017!

We are happy to announce that EMPE Diagnostics has been selected for the round-table presentation under the topic future diagnostics! Come and meet us at the 38:th Annual European Society of Mycobacteriology Congress at Šibenik, Croatia!

Posted June 5, 2017
Read More..

Partnering with Q-linea

We are happy to announce that EMPE Diagnostics is partnering with the Swedish company, Q-linea AB who has years of experience in developing rapid diagnostics! Q-linea’s fully automated solutions cut the diagnostic time for sepsis and deliver clinically-actionable results in hours instead of days.

Posted March 1, 2017
Read More..

TBnet collaboration

With immense of optimism and confidence, we have agreed to perform a multi-national clinical evaluation for the assessment of our first product, the mfloDx® MDR-TB test. The product will be validated in at least seven WHO sponsored Supernational Reference Laboratories in Europe and Asia. The clinical evaluation is scheduled to start in Jan. 2018.

Posted October 20, 2016
Read More..

EMPE has received first collaborative research grant!

It is our pleasure to announce that EMPE has received a collaborative research grant to develop a new RCA-ADT rapid detection platform for diarrhoeagenic E. coli and Vibrio Cholerae. The consortium includes University of Loughborough (UK), University of Cambridge (UK), International Centre for Diarrhoeal Disease Research (Bangladesh) and Stockholm University (Sweden).

Posted August 15, 2016
Read More..

EMPE has appointed its first employee

We are happy to announce the employment of Mr. Jeanpierre Salas, a Biotechnical Engineer from the famous Royal Institute of Technology. Jeanpierre will work on the technical aspects of assay integration and lateral-flow cassette assembling dynamics. Welcome Jeanpierre!

Posted July 25, 2016
Read More..